Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ardent Health (ARDT) EBITDA (2023 - 2025)

Historic EBITDA for Ardent Health (ARDT) over the last 3 years, with Q3 2025 value amounting to -$278.1 million.

  • Ardent Health's EBITDA fell 4275.73% to -$278.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$708.2 million, marking a year-over-year increase of 1300.29%. This contributed to the annual value of -$670.1 million for FY2024, which is 2040.04% up from last year.
  • According to the latest figures from Q3 2025, Ardent Health's EBITDA is -$278.1 million, which was down 4275.73% from -$148.6 million recorded in Q2 2025.
  • In the past 5 years, Ardent Health's EBITDA registered a high of -$96.8 million during Q4 2024, and its lowest value of -$278.1 million during Q3 2025.
  • Moreover, its 3-year median value for EBITDA was -$189.9 million (2023), whereas its average is -$191.1 million.
  • Per our database at Business Quant, Ardent Health's EBITDA soared by 5979.41% in 2024 and then crashed by 4275.73% in 2025.
  • Over the past 3 years, Ardent Health's EBITDA (Quarter) stood at -$240.9 million in 2023, then skyrocketed by 59.79% to -$96.8 million in 2024, then tumbled by 187.15% to -$278.1 million in 2025.
  • Its EBITDA was -$278.1 million in Q3 2025, compared to -$148.6 million in Q2 2025 and -$184.7 million in Q1 2025.